.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Dow
Queensland Health
Cipla
Healthtrust
Chubb
US Department of Justice
Argus Health
Cerilliant
AstraZeneca

Generated: September 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090072

« Back to Dashboard
NDA 090072 describes PERINDOPRIL ERBUMINE, which is a drug marketed by Ani Pharms Inc, Apotex, Lupin Ltd, Aurobindo Pharma, and West-ward Pharms Int, and is included in five NDAs. It is available from three suppliers. Additional details are available on the PERINDOPRIL ERBUMINE profile page.

The generic ingredient in PERINDOPRIL ERBUMINE is perindopril erbumine. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the perindopril erbumine profile page.

Summary for NDA: 090072

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents

Pharmacology for NDA: 090072

Suppliers and Packaging for NDA: 090072

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL 090072 ANDA West-Ward Pharmaceuticals Corp. 0054-0110 0054-0110-25 100 TABLET in 1 BOTTLE (0054-0110-25)
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL 090072 ANDA West-Ward Pharmaceuticals Corp. 0054-0111 0054-0111-25 100 TABLET in 1 BOTTLE (0054-0111-25)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Nov 10, 2009TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG
Approval Date:Nov 10, 2009TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength8MG
Approval Date:Nov 10, 2009TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Deloitte
McKesson
Queensland Health
Mallinckrodt
Baxter
Harvard Business School
Moodys
US Army
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot